Patent · US Active

Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them

US8859814B2 · kind B2 · utility

0Cited by

2References

4Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Derek Cogan · Sandy Hook, US
Alexander Heim-Riether · Ingelheim am Rhein, DE
Wang Mao · Milford, US
Craig Andrew Miller · Penfield, US
Philip Dean Ramsden · Cambridge, US
Lana Louise Smith Keenan · Poughquag, US
Roger John Snow · Danbury, US
Jiang-Ping Wu · Lexington, US
Yu Yang · Clark, US

Key dates

Filing date	May 14, 2009
Grant date	Oct 14, 2014
Priority date	—
Expiry date	Mar 30, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed is a compound of formula (I). Wherein R1, R2Ar and Cy are as defined herein, or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions of the compound of formula (I), methods of making the compounds of formula I, and methods of using the compounds of formula (I) to treat a disorder associated with activation of CCR10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.